InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,542.48
(
0.61%
)
US TECH 100
19,769.90
(
0.65%
)
Dow Jones
39,275.81
(
-0.08%
)
Brent Oil
87.46
(
0.14%
)
Bitcoin
55,931.99
(
-1.84%
)
Post# of 252489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 79867

Wednesday, 11/02/2011 7:22:10 AM

Wednesday, November 02, 2011 7:22:10 AM

Post# of 252489
FDA approves ABT’s Xience Prime drug-eluting stent:

http://finance.yahoo.com/news/Abbott-Receives-US-FDA-prnews-2224425868.html?x=0&.v=1

XIENCE PRIME, which uses the same drug and biocompatible polymer as the XIENCE V Everolimus Eluting Coronary Stent System, features an enhanced stent design and a delivery system designed for greater flexibility, ideal radial strength, excellent longitudinal strength and more accurate stent placement.

Xience Prime was approved in Europe two years ago (#msg-38985789).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up